Jefferies Financial Group’s AtriCure ATRC Stock Holding History

Jefferies Financial Group’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,349	Closed	-$322K	–	1689
2023 Q3	$322K	Buy	+7,349	New	+$359K	﹤0.01%	1210
2023 Q2	–	Sell	-52,910	Closed	-$2.19M	–	1672
2023 Q1	$2.19M	Buy	+52,910	New	+$2.2M	0.02%	629

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jefferies Financial Group's ATRC Position: Q4 2023 in Review

Jefferies Financial Group sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 7,349 shares — an estimated $322K sold.

Jefferies Financial Group first reported a position in ATRC in Q1 2023 and held it in 2 quarters. The position peaked at $2.19M in Q1 2023. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

Jefferies Financial Group reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
Jefferies Financial Group sold 7,349 AtriCure shares in Q4 2023, an estimated $322K.
Jefferies Financial Group first reported a position in AtriCure in Q1 2023 and held it in 2 quarters.
Jefferies Financial Group's AtriCure position peaked at $2.19M in Q1 2023.
233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Jefferies Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.